RB1 and prostate cancer: Our Figure 5 showed a reduction of AXL and survivin, two known aggressiveness-regulating molecules of prostate cancer [26,27,28,42], by combinatorial lovastatin and AC extract, which echoed the roles of RB in cancer control.